The high cytoplasmic FOXO3 expression rates in this panel of HER2+ breast cancer samples could also be the reason why a good correlation analysis between PERK and cytoplasmic FOXO3 expression can be made. This evidence concerns the gene ERBB2 and breast carcinoma.